SRRM4 and neoplasm: Probing the GEPIA interactive web server, which incorporates over 18,000 matched tumor and normal samples from the TCGA and GTEx projects [60], we identified SRRM4 was significantly reduced in both GBM tumors and low-grade gliomas compared with healthy tissues (Figure S4a).